In addition, RNAi loss-of-function studies demonstrated that Bcl2L12 neutralization sensitized glioma cells toward apoptosis, and most importantly, reduced intracranial tumor formation with increased apoptotic, decreased proliferative indices, and enhanced tumor-free survival [31]. The gene discussed is BCL2L12; the disease is glioma.